Suppr超能文献

原发性甲状旁腺功能亢进症中HRPT2基因的遗传学分析:家族性和散发性甲状旁腺肿瘤中的胚系和体细胞突变

Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.

作者信息

Cetani Filomena, Pardi Elena, Borsari Simona, Viacava Paolo, Dipollina Giada, Cianferotti Luisella, Ambrogini Elena, Gazzerro Elisabetta, Colussi Giacomo, Berti Piero, Miccoli Paolo, Pinchera Aldo, Marcocci Claudio

机构信息

Dipartimento di Endocrinologia e Metabolismo, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy.

出版信息

J Clin Endocrinol Metab. 2004 Nov;89(11):5583-91. doi: 10.1210/jc.2004-0294.

Abstract

We investigated the involvement of the HRPT2 gene by loss of heterozygosity analysis and direct sequencing in a kindred with hyperparathyroidism-jaw tumor syndrome (HPT-JT) and three kindreds with familial isolated primary hyperparathyroidism (FIHP). Seven patients with sporadic parathyroid cancers and 35 with parathyroid adenomas with no family history of primary hyperparathyroidism or HPT-JT were also studied. A germline heterozygous substitution G to A was found in the donor splice site of intron 1 in one of the three FIHP families. No mutations were identified in the HPT-JT kindred. A somatic HRPT2 mutation was found in four of seven patients with parathyroid cancers, two of which were unreported frameshift mutations (195insT and 195insA) in exon 2. Consistent with recent findings, two of seven patients with sporadic parathyroid cancer had germline mutations. Four adenomas showed loss of heterozygosity at HRPT2, whereas a somatic HRPT2 mutation was found in one. In conclusion, we provide additional evidence for a strong association between HRPT2 gene mutations and sporadic parathyroid cancer. The finding that two of the seven patients with sporadic parathyroid cancer carried an HRPT2 germline mutation suggests that they might have occult HPT-JT. Our results also confirm the need for testing HRPT2 gene in FIHP families.

摘要

我们通过杂合性缺失分析和直接测序,对一个患有甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)的家系以及三个患有家族性孤立性原发性甲状旁腺功能亢进(FIHP)的家系中的HRPT2基因进行了研究。还对7例散发性甲状旁腺癌患者和35例无原发性甲状旁腺功能亢进或HPT-JT家族史的甲状旁腺腺瘤患者进行了研究。在三个FIHP家族之一的1号内含子供体剪接位点发现了一个种系杂合性G到A的替换。在HPT-JT家系中未发现突变。在7例甲状旁腺癌患者中有4例发现了体细胞HRPT2突变,其中2例是外显子2中未报道的移码突变(195insT和195insA)。与最近的研究结果一致,7例散发性甲状旁腺癌患者中有2例有种系突变。4例腺瘤显示HRPT2杂合性缺失,而在1例中发现了体细胞HRPT2突变。总之,我们为HRPT2基因突变与散发性甲状旁腺癌之间的强关联提供了额外证据。7例散发性甲状旁腺癌患者中有2例携带HRPT2种系突变,这一发现表明他们可能患有隐匿性HPT-JT。我们的结果也证实了对FIHP家族进行HRPT2基因检测的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验